Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD)

NCT00373334 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease
GERD
Heartburn

Interventions

DRUG: nizatidine (axid)
DRUG: nizatidine (axid)
DRUG: placebo

Sponsor

Braintree Laboratories